The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low incidence of hepatic veno-occlusive disease (VOD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin (INO) followed by allogeneic stem cell transplantation (allo-SCT).
 
Kirk Cahill
No Relationships to Disclose
 
Juan Alban
No Relationships to Disclose
 
Mylove Mortel
No Relationships to Disclose
 
Emily Dworkin
No Relationships to Disclose
 
Satyajit Kosuri
No Relationships to Disclose
 
Adam Duvall
No Relationships to Disclose
 
Hongtao Liu
Consulting or Advisory Role - Agios
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst)
 
Michael Russell Bishop
Employment - UnitedHealthcare
Honoraria - Celgene
Consulting or Advisory Role - AGIOS; Arcellx; Arcellx; Autolus; Bluebird Bio; BMS; crispr therapeutics; Iovance Biotherapeutics; Kite, a Gilead company; Novartis; Seagen
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Richard A. Larson
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Celgene; CVS Caremark; DAVA Pharmaceuticals; Epizyme; Novartis
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Cellectis (Inst); Daiichi Sankyo (Inst); Forty Seven (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Wendy Stock
Honoraria - Abbvie
Consulting or Advisory Role - Adaptive Biotechnologies; agios; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; morphosys; Pfizer; SERVIER
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer